Skip to main content

ML P19 8 mg (Doxazosin Mesylate 8 mg)

Pill with imprint ML P19 8 mg is Green, Elliptical/Oval and has been identified as Doxazosin Mesylate 8 mg. It is supplied by Dava Pharmaceuticals Inc.

Doxazosin is used in the treatment of high blood pressure; benign prostatic hyperplasia; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Doxazosin 8 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for ML P19 8 mg

Doxazosin mesylate 8 mg ML P19 8 mg
Doxazosin mesylate 8 mg ML P19 8 mg Front
Doxazosin mesylate 8 mg ML P19 8 mg Back
Doxazosin mesylate 8 mg ML P19 8 mg

Doxazosin Mesylate

ML P19 8 mg
8 mg
13.00 mm
Prescription only
Drug Class
Antiadrenergic agents, peripherally acting
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dava Pharmaceuticals Inc.
National Drug Code (NDC)
67253-0383 (Discontinued)
Inactive Ingredients
microcrystalline cellulose, sodium starch glycolate type B potato, magnesium stearate, sodium lauryl sulfate, FD&C Blue No. 2, D&C Yellow No. 10, aluminum oxide, lactose

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.